—

Lantheus Holdings Inc (LNTH) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 60 out of 100 (momentum 72 · quality 73 · valuation 55), as of 2026-11-03.
  • Signal: Uptrend stack intact — Trades +0% vs the 50-day and +9.6% vs the 200-day average, 10.3% below the 52-week high and +100% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: Lantheus Holdings Inc trades 0.0% above its 50-day and 9.6% above its 200-day moving average. (as of 2026-11-02)

Lantheus develops diagnostic and therapeutic products used in imaging and treating heart disease, cancer and other conditions. Its portfolio includes DEFINITY for echocardiography, TechneLite and Xenon-133 for nuclear medicine, and PYLARIFY, a PET imaging agent used to detect prostate cancer.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the LNTH overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +0% vs the 50-day and +9.6% vs the 200-day average, 10.3% below the 52-week high and +100% off the 52-week low. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on LNTH?

Uptrend stack intact — Trades +0% vs the 50-day and +9.6% vs the 200-day average, 10.3% below the 52-week high and +100% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is LNTH above its 50-day and 200-day moving averages?

As of 2026-11-02, Lantheus Holdings Inc trades +0% above its 50-day and +9.6% above its 200-day average, with the 20-day +0.2% away.

How far is LNTH from its 52-week high?

10.3% below the 52-week high and 100% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.